Global Antibacterial Drugs Market: Overview This report provides in-depth region wise and country wise analysis of the antibacterial drugs market. Stakeholders of this report include manufacturers of antibacterial drugs, raw material suppliers, researchers and new players planning to enter the market.
The report provides qualitative and quantitative analysis of the global antibacterial drugs market. Qualitative analysis comprises market dynamics, trends, product overview, and country-level market information. Quantitative analysis includes market share held by companies, market size, and forecast for the global antibacterial drugs market in major countries globally such as the U.S., Canada, Germany, France, United Kingdom, Japan, China,, India, Brazil, Mexico, South Africa GCC countries and others.
Market revenue is provided in terms of US$ Mn from 2015 to 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 for all the segments, considering 2016 as the base year. The executive summary of the report provides a snapshot of the antibacterial drugs with information on leading segments, country wise market information with respect to the market size, growth rate (CAGR %), and growth factors.
Global Antibacterial Drugs Market: Scope of the Study The market overview section comprises impact factors such as drivers, restraints, and opportunities for the global antibacterial drugs market. These factors would aid the stakeholders in establishing a strong foothold in the global antibacterial drugs market. Furthermore, the market overview section comprises key industry events, product overview, market attractiveness analysis and emerging trend in the antibacterial drugs. The market attractiveness analysis provides a graphical view comparing the growth and market dynamics in various segments and country wise to identify the most attractive market.
Global Antibacterial Drugs Market: Key Segments Based on drug class, the global antibacterial drugs market is classified into B – lactams, quinolones, macrolides, tetracycline, aminoglycoside, sulfonamide, phenicols, and others. In terms of routes of administration, the global antibacterial drugs market has been segmented into enteral, parenteral and others. Likewise, the global antibacterial drugs market has been further segmented into hospital pharmacies, drug stores and retail pharmacies and online sales, in terms of distribution channel. The retail stores and drug stores segment is anticipated to experience the largest market share in 2016 and this segment will grow by a significant rate during the forecast period.
Global Antibacterial Drugs Market: Regional Outlook Geographically, the antibacterial drugs market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, analysis for the major countries comprising U.S. Canada, Germany, U.K., France, Japan, China, India, Brazil, Mexico, and South Africa and others have also been provided in the report. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the antibacterial drugs market in various regions has been provided in this section.
Global Antibacterial Drugs Market: Competitive Outlook This report also includes various ups and downs about particular country or geography that has impacted the overall market globally. The report provides a detailed outline/blueprint of the antibacterial drugs market globally that will assist new companies in establishing their presence and market players in expanding their market share in the market. The report concludes with the company profile section which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies and recent developments for market players. Prominent key players are Bayer AG, Pfizer Inc., Sanofi, GlaxoSmithKline Plc. (GSK), Merck & Co., Inc., AstraZeneca, Johnson and Johnson, Bristol Myers Squibb Company, Novartis AG, and Allergen plc
Global antibacterial drugs market is segmented as given below: Global Antibacterial Drugs Market, by Drug Class B – lactams Quinolones Macrolides Tetracycline Aminoglycoside Sulfonamide Phenicols Others
Global Antibacterial Drugs Market, by Routes of Administration Enteral, Parenteral Others
Global Antibacterial Drugs Market, by Distribution Channel Hospital Pharmacies Drug Stores and Retail Pharmacies Online Sales
Global Antibacterial Drugs Market, by Geography North America U.S. Canada Europe Germany France U.K. Rest of Europe Asia Pacific (APAC) China Japan India Rest of APAC Latin America (LATAM) Brazil Mexico Rest of LATAM Middle East & Africa (MEA) GCC South Africa Rest of Middle East & Africa
Our reports have been used by over 10K customers, including:
The global demand for Resorcinol is forecast to report strong growth driven by consumption in major emerging markets.More growth opportunities will turn up between 2018 and 2025 as compared to the past five years, suggesting rapid pace of change. Companies quickly adapting to this changing landscape are emerging as top performers and...
The global demand for Benzyl Alcohol is forecast to report strong growth driven by consumption in major emerging markets.More growth opportunities will turn up between 2018 and 2025 as compared to the past five years, suggesting rapid pace of change. Companies quickly adapting to this changing landscape are emerging as top performers...
Comprehensive Pipeline Review on Ongoing Clinical and Pre-clinical studies Methicillin Susceptible Staphylococcus aureus Infections Drug Development Pipeline Study is the latest publication from VPA Research with comprehensive information of Methicillin Susceptible Staphylococcus aureus Infections pipeline products. The Methicillin...
The global small molecule drug discovery market is expected to witness a CAGR of 6.8% during the forecast period (2018-2023). North America dominates the market due to a rise of chronic disease in that region. Rise in Demand for Small Molecule Drugs Small molecule drugs accounted for 84% of the total pharmaceutical industry revenue...
The Global Antibiotics Market is expected to reach USD XX million by 2022 from USD XX million in 2016, at a CAGR of XX%. Antibiotic resistance accounts for 50,000 deaths per year in the US and Europe alone. Routine surgeries and minor infections might become life threatening if novel antibiotics are not developed. In spite of microbial resistance...